DAPAGLIFLOZIN | DAPAGLIFLOZIN | ATC A10BX09 ATC A10BD15 ATC A10BK01 ATC A10BD25 ATC A10BD21
METABOLISM A SODIUM-GLUCOSE COTRANSPORTER 2 (SGLT2) INHIBITOR TREATMENT OF TYPE 2 DIABETES MELLITU IMPROVE GLYCEMIC CONTROL | ORAL | Tmax 2 HOUR F 78 PERCENT PPB 91 PERCENT HT 12.9 HOUR | SODIUM-GLUCOSE COTRANSPORTER 2 (SGLT2) | SODIUM/GLUCOSE COTRANSPORTER 2 INHIBITOR CHEMBL3884 SODIUM/GLUCOSE COTRANSPORTER 2 P31639 SODIUM/GLUCOSE COTRANSPORTER 2 HOMO SAPIENS TRANSPORTER ELECTROCHEMICAL SLC SLC05 | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |